- Home
- PED vs ANTX Comparison
PED vs ANTX Comparison
Compare PED & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PED | ANTX |
|---|---|---|
| Founded | N/A | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 155.8M | 170.7M |
| IPO Year | 2012 | 2022 |
Fundamental Metrics
Financial Performance| Metric | PED | ANTX |
|---|---|---|
| Price | $12.49 | $4.42 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $30.00 | $2.00 |
| AVG Volume (30 Days) | 63.5K | ★ 383.9K |
| Earning Date | 05-15-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 32.56 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $45,751,000.00 | N/A |
| Revenue This Year | $171.75 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 15.67 | N/A |
| 52 Week Low | $0.43 | $1.00 |
| 52 Week High | $18.89 | $6.91 |
Technical Indicators
Market Signals| Indicator | PED | ANTX |
|---|---|---|
| Relative Strength Index (RSI) | 45.42 | 44.46 |
| Support Level | $11.37 | $3.82 |
| Resistance Level | $14.20 | $5.21 |
| Average True Range (ATR) | 1.25 | 0.40 |
| MACD | 0.12 | -0.05 |
| Stochastic Oscillator | 21.44 | 0.91 |
Price Performance
Historical ComparisonAbout PED Pedevco Corp.
PEDEVCO Corp is an oil and gas company focused on oil and natural gas development, exploration, and production. The company focuses on legacy properties with a long production history, well-defined geology, and existing infrastructure that can be leveraged when applying modern field management technologies. The current properties in the Denver-Julesberg Basin (D-J Basin) in Colorado and Wyoming, the Powder River Basin (PRB) in Wyoming, and the San Andres formation of the Permian Basin situated in West Texas and eastern New Mexico (the Permian Basin).
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.